Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Abbott Laboratories (ABT) - free report >>
Apartment Investment and Management Company (AIV) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Abbott Laboratories (ABT) - free report >>
Apartment Investment and Management Company (AIV) - free report >>
Image: Bigstock
Top Ranked Momentum Stocks to Buy for February 11th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, February 11th:
Apartment Investment and Management Company (AIV - Free Report) : This real estate investment trust has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.4% over the last 60 days.
Apartment Investment and Management Company Price and Consensus
Apartment Investment and Management Company price-consensus-chart | Apartment Investment and Management Company Quote
Apartment Investment's shares gained 8.9% over the last one month more than S&P 500’s gain of 4.9%. The company possesses a Momentum Score of B.
Apartment Investment and Management Company Price
Apartment Investment and Management Company price | Apartment Investment and Management Company Quote
ABIOMED, Inc. : This developer and seller of medical devices has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.2% over the last 60 days.
ABIOMED, Inc. Price and Consensus
ABIOMED, Inc. price-consensus-chart | ABIOMED, Inc. Quote
ABIOMED’s shares gained 8.2% over the last one month. The company possesses a Momentum Score of A.
ABIOMED, Inc. Price
ABIOMED, Inc. price | ABIOMED, Inc. Quote
Abbott Laboratories (ABT - Free Report) : This developer and manufacturer of health care products has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.3% over the last 60 days.
Abbott Laboratories Price and Consensus
Abbott Laboratories price-consensus-chart | Abbott Laboratories Quote
Abbott Laboratories’ shares gained 7.4% over the last one month. The company possesses a Momentum Score of B.
Abbott Laboratories Price
Abbott Laboratories price | Abbott Laboratories Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Is Your Investment Advisor Fumbling Your Financial Future?
See how you can more effectively safeguard your retirement with a new Special Report, “4 Warning Signs Your Investment Advisor Might Be Sabotaging Your Financial Future.”
Click to get it free >>